SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:90d6c998-b27f-43eb-996a-5aa83f481fa5"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:90d6c998-b27f-43eb-996a-5aa83f481fa5" > The gut microbiota ...

The gut microbiota and diabetes : research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum

Byndloss, Mariana (författare)
Vanderbilt University Medical Center
Devkota, Suzanne (författare)
Cedars-Sinai Medical Center
Duca, Frank (författare)
University of Arizona
visa fler...
Niess, Jan Hendrik (författare)
University of Basel
Nieuwdorp, Max (författare)
Academic Medical Center of University of Amsterdam (AMC)
Orho-Melander, Marju (författare)
Lund University,Lunds universitet,Diabetes - kardiovaskulär sjukdom,Forskargrupper vid Lunds universitet,Diabetes - Cardiovascular Disease,Lund University Research Groups
Sanz, Yolanda (författare)
CSIC - Institute Of Agrochemistry And Food Technology (IATA)
Tremaroli, Valentina (författare)
University of Gothenburg
Zhao, Liping (författare)
Rutgers University: The State University of New Jersey
visa färre...
 (creator_code:org_t)
2024
2024
Engelska.
Ingår i: Diabetologia. - 0012-186X.
  • Forskningsöversikt (refereegranskat)
Abstract Ämnesord
Stäng  
  • This article summarises the state of the science on the role of the gut microbiota (GM) in diabetes from a recent international expert forum organised by Diabetes, Diabetes Care, and Diabetologia, which was held at the European Association for the Study of Diabetes 2023 Annual Meeting in Hamburg, Germany. Forum participants included clinicians and basic scientists who are leading investigators in the field of the intestinal microbiome and metabolism. Their conclusions were as follows: (1) the GM may be involved in the pathophysiology of type 2 diabetes, as microbially produced metabolites associate both positively and negatively with the disease, and mechanistic links of GM functions (e.g. genes for butyrate production) with glucose metabolism have recently emerged through the use of Mendelian randomisation in humans; (2) the highly individualised nature of the GM poses a major research obstacle, and large cohorts and a deep-sequencing metagenomic approach are required for robust assessments of associations and causation; (3) because single time point sampling misses intraindividual GM dynamics, future studies with repeated measures within individuals are needed; and (4) much future research will be required to determine the applicability of this expanding knowledge to diabetes diagnosis and treatment, and novel technologies and improved computational tools will be important to achieve this goal.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Nyckelord

Butyrate
Faecal microbiota transplantation
Gastrointestinal microbiota
Gastrointestinal tract microbiology
Gut microbiota
Large intestine microbiota
Metagenomics
Microbiota metabolites
Review
Short-chain fatty acids
Small intestine microbiota

Publikations- och innehållstyp

for (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy